SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-020886
Filing Date
2022-08-04
Accepted
2022-08-04 08:31:06
Documents
74
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cccc-20220630.htm   iXBRL 10-Q 1750767
2 EX-31.1 cccc-20220630xexx311.htm EX-31.1 10471
3 EX-31.2 cccc-20220630xexx312.htm EX-31.2 10517
4 EX-32.1 cccc-20220630xexx321.htm EX-32.1 4842
5 EX-32.2 cccc-20220630xexx322.htm EX-32.2 4853
  Complete submission text file 0001628280-22-020886.txt   7321450

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cccc-20220630.xsd EX-101.SCH 53198
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cccc-20220630_cal.xml EX-101.CAL 73003
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cccc-20220630_def.xml EX-101.DEF 214754
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cccc-20220630_lab.xml EX-101.LAB 601814
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cccc-20220630_pre.xml EX-101.PRE 383243
68 EXTRACTED XBRL INSTANCE DOCUMENT cccc-20220630_htm.xml XML 1179151
Mailing Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

IRS No.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39567 | Film No.: 221134875
SIC: 2836 Biological Products, (No Diagnostic Substances)